Clinical Trial Update: Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous cultured adipose-derived stem cells for Crohn's fistula has completed. The study reports safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Autologous Cultured Adipose-Derived Stem Cells (adipose-derived stem cells (autologous, cultured))

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Crohn's Fistula | Phase 2 | Status: COMPLETED